MAHON PAUL A
- SEC CIK
- 0001231589
在各公司的最新職務
- UTHR UNITED THERAPEUTICS Corp執行副總裁、法務長2026/9/18 申報
交易紀錄
所有把 MAHON PAUL A 列為申報人的 Form 4，包括與他人共同申報的。每一列是一份申報裡同一種交易的合計；預設只顯示公開市場買進（P）與賣出（S）。
| 公司 | 申報時間（美東） | 交易日 | 內部人 | 交易 | 股數 | 均價 | 金額 | 交易後持股 | 持股變化 | 申報 |
|---|---|---|---|---|---|---|---|---|---|---|
| UTHRUNITED THERAPEUTICS Corp | 2026/9/1816:40 ET | 2026/9/17 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $497.5431 | −$412.96 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/9/316:32 ET | 2026/9/3 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $482.0285 | −$400.08 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/8/2116:43 ET | 2026/8/20 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $523.1421 | −$434.21 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/8/616:35 ET | 2026/8/6 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $517.0497 | −$429.15 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/7/1616:30 ET | 2026/7/16 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $533.6913 | −$442.96 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/7/216:32 ET | 2026/7/2 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $552.5632 | −$458.63 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/6/18 | 2026/6/18 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $541.5486 | −$449.49 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/6/4 | 2026/6/4 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $547.0667 | −$454.07 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/5/21 | 2026/5/21 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $562.8201 | −$467.14 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/5/7 | 2026/5/7 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $586.754 | −$487.01 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/4/16 | 2026/4/16 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $576.8187 | −$478.76 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/4/2 | 2026/4/2 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $565.8657 | −$469.67 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/3/19 | 2026/3/19 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $529.9523 | −$439.86 萬 | 4.52 萬 | −15.5% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/3/5 | 2026/3/5 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $483.155 | −$401.02 萬 | 3.68 萬 | −18.4% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/2/19 | 2026/2/19 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $476.3369 | −$395.36 萬 | 3.68 萬 | −18.4% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/2/5 | 2026/2/5 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $483.2443 | −$401.09 萬 | 3.68 萬 | −18.4% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/1/15 | 2026/1/15 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $469.8943 | −$390.01 萬 | 3.68 萬 | −18.4% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2026/1/2 | 2026/1/2 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −8,300 | $485.4318 | −$402.91 萬 | 3.68 萬 | −18.4% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/12/29 | 2025/12/24 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $513.1753 | −$564.49 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/12/12 | 2025/12/11 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $484.6681 | −$533.13 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/11/26 | 2025/11/26 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $486.065 | −$534.67 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/11/13 | 2025/11/13 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $464.7592 | −$511.24 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/10/30 | 2025/10/30 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $450.3413 | −$495.38 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/10/20 | 2025/10/16 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $431.5007 | −$474.65 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/10/2 | 2025/10/2 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $436.5983 | −$480.26 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/9/18 | 2025/9/18 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $406.1732 | −$446.79 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/9/5 | 2025/9/4 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $385.2065 | −$423.73 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/8/22 | 2025/8/21 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $308.7518 | −$339.63 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/8/8 | 2025/8/7 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $299.9992 | −$330 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/7/25 | 2025/7/24 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $304.1103 | −$334.52 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/7/14 | 2025/7/10 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $300.3103 | −$330.34 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/6/27 | 2025/6/26 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $285.7012 | −$314.27 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/6/16 | 2025/6/12 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $279.9561 | −$307.95 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/5/30 | 2025/5/29 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $316.0702 | −$347.68 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/5/20 | 2025/5/15 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $295.1049 | −$324.62 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/5/2 | 2025/5/1 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $300.9284 | −$331.02 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/4/18 | 2025/4/17 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $283.7787 | −$312.16 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2025/4/7 | 2025/4/3 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −1.1 萬 | $306.1799 | −$336.8 萬 | 3.68 萬 | −23.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2024/12/6 | 2024/12/5 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −7,700 | $374.37 | −$288.26 萬 | 3.67 萬 | −17.3% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2024/11/22 | 2024/11/21 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −7,700 | $367.36 | −$282.87 萬 | 3.67 萬 | −17.3% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2024/4/4 | 2024/4/4 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −6,000 | $232.3729 | −$139.42 萬 | 3.67 萬 | −14.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2024/3/22 | 2024/3/21 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −6,000 | $236.4514 | −$141.87 萬 | 3.67 萬 | −14.0% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2024/3/7 | 2024/3/7 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −6,000 | $237.3845 | −$142.43 萬 | 3.66 萬 | −14.1% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2024/2/15 | 2024/2/15 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −6,000 | $215.3107 | −$129.19 萬 | 3.66 萬 | −14.1% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2024/2/2 | 2024/2/1 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −6,000 | $215.0178 | −$129.01 萬 | 3.66 萬 | −14.1% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2024/1/18 | 2024/1/18 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −6,000 | $218.7212 | −$131.23 萬 | 3.66 萬 | −14.1% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2024/1/5 | 2024/1/4 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −6,000 | $227.9665 | −$136.78 萬 | 3.66 萬 | −14.1% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2023/12/26 | 2023/12/21 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −6,000 | $229.2642 | −$137.56 萬 | 3.66 萬 | −14.1% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2023/12/7 | 2023/12/7 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −6,000 | $238.8933 | −$143.34 萬 | 3.66 萬 | −14.1% | SEC10b5-1 |
| UTHRUNITED THERAPEUTICS Corp | 2023/11/17 | 2023/11/16 | MAHON PAUL A執行副總裁、法務長 | S賣出Common Stock | −6,000 | $226.5989 | −$135.96 萬 | 3.66 萬 | −14.1% | SEC10b5-1 |